Immune-Related Adverse Events of Immune Checkpoint Inhibitors-From a Clinical to Pathophysiological View-In Reply
JAMA Oncol
.
2019 Dec 1;5(12):1805.
doi: 10.1001/jamaoncol.2019.4055.
Authors
Fiamma Berner
1
,
David Bomze
1
,
Lukas Flatz
1
Affiliation
1
Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
PMID:
31580393
DOI:
10.1001/jamaoncol.2019.4055
No abstract available